Tech Company Financing Transactions

AsclepiX Therapeutics Funding Round

AsclepiX Therapeutics secured a $10 million Series A funding round on 7/26/2023. Investors included Perceptive Advisors, Hibiscus Capital Management and Rapha Capital Management.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

301 West 29th St. 2004
Baltimore, MD 21211
USA

Phone

(410) 657-2627

Website

www.asclepix.com

Email Address

[email protected]

Overview

AsclepiX Therapeutics is focussed on transforming the treatment of retinal disease and cancer through the rapid clinical development of groundbreaking therapies which may empower patients and families around the world with the freedom to live their best lives.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Kevin Slawin

        

Chief Medical Officer

Theresa Heah

        

Chief Scientific Officer

Aleksander Popel

        

Chief Technical Officer

Jordan Green

        

VP - R & D

Niranjan Pandey

        

VP - R & D

Huan Sheng

        

Browse more venture capital transactions:

Prev: 7/26/2023: Dioxycle venture capital transaction
Next: 7/26/2023: Verrica Pharmaceuticals venture capital transaction

Share this article

Where The Data Comes From

We do our best to record all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary